PT - JOURNAL ARTICLE AU - Xiaoping Chen AU - Jiaxin Ling AU - Pingzheng Mo AU - Yongxi Zhang AU - Qunqun Jiang AU - Zhiyong Ma AU - Qian Cao AU - Wenjia Hu AU - Shi Zou AU - Liangjun Chen AU - Lei Yao AU - Mingqi Luo AU - Tielong Chen AU - Liping Deng AU - Ke Liang AU - Shihui Song AU - Rongrong Yang AU - Ruiying Zheng AU - Shicheng Gao AU - Xien Gui AU - Hengning Ke AU - Wei Hou AU - Åke Lundkvist AU - Yong Xiong TI - Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients AID - 10.1101/2020.03.03.20030437 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.03.20030437 4099 - http://medrxiv.org/content/early/2020/03/06/2020.03.03.20030437.short 4100 - http://medrxiv.org/content/early/2020/03/06/2020.03.03.20030437.full AB - Background Viral clearance is one important indicator for the recovery of SARS-CoV-2 infected patients. Previous studies have pointed out that suboptimal T and B cell responses can delay viral clearance in MERS-CoV and SARS-CoV infected patients. The role of leukomonocytes in viral clearance of COVID-19 patients is not yet well defined.Methods From January 26 to February 28, 2020, an observational study was launched at the Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China. We enrolled 25 laboratory-confirmed COVID-19 patients, whose throat-swab specimens were tested positive for SARS-CoV-2 infection by qRT-PCR. To investigate the factors that contribute to the viral clearance, we comprehensively analyzed clinical records, counts of lymphocyte subsets including CD3+, CD4+, CD8+ T cells, B cells and NK cells in the patients who successfully cleared SARS-CoV-2, and compared to those that failed to, after a standardized treatment of 8-14 days.Findings In 25 enrolled COVID-19 patients, lymphopenia was a common feature. After the treatment, 14 out of the 25 enrolled patients were tested negative for SARS-CoV-2. The patients that cleared the infection had restored the numbers of CD3+, CD4+, CD8+ T cells and B cells as compared to the still viral RNA positive patients, while the recovered patients had a higher count of leukomonocytes.Conclusions By comparison of leukomonocytes counts in COVID-19 patients at different stages of the disease, we found that CD3+, CD4+, CD8+ T cells and B cells appear to play important roles in viral clearance. The restoration of leukomonocytes counts from peripheral blood can be used as prognosis for the recovery of an COVID-19 infection. We propose that restoration of leukomonocytes counts can be added to the COVID-19 diagnostic guidance as a criterion for releasing and discharging patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund, grant number znpy2018007 and the Swedish Research Council, grant number 2017-05807. The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript. The authors declared no competing interests. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are availability.